Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines

Background:  Burning mouth syndrome (BMS) is considered a syndrome with an unknown cause. Roles of various trace elements and cytokines in saliva have been implicated in the development of BMS. The aim of the present study was to compare the levels of salivary trace elements [magnesium (Mg), zinc (Z...

Full description

Saved in:
Bibliographic Details
Published inJournal of oral pathology & medicine Vol. 38; no. 3; pp. 269 - 275
Main Authors Pekiner, F. N., Gümrü, B., Demirel, G. Y., Özbayrak, S.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.2009
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background:  Burning mouth syndrome (BMS) is considered a syndrome with an unknown cause. Roles of various trace elements and cytokines in saliva have been implicated in the development of BMS. The aim of the present study was to compare the levels of salivary trace elements [magnesium (Mg), zinc (Zn), copper (Cu)] and interleukin (IL)‐2 and IL‐6, and to search for a correlation between depression/anxiety and salivary trace elements and cytokines in BMS patients and controls. Methods:  Thirty patients with BMS and 30 matched healthy controls participated in the study. Unstimulated saliva was collected from participants and salivary flow rates were determined. Mg, Zn and Cu levels were determined by atomic absorbance spectrophotometry. Cytokine immunoassay kits were used to determine the concentration of IL‐2 and IL‐6 in the whole saliva samples. Anxiety and depression were analyzed by means of the Speilberger State‐Trait Anxiety Inventory (SAI‐TAI) and Zung Self‐Rating Depression Scale. Results:  Although subjects in the control group had significantly higher mean levels for Mg compared with BMS patients (P < 0.01), no statistically significant differences were observed in relation to Zn and Cu levels between the two groups (P < 0.001). There were no statistically significant differences in IL‐2 and IL‐6 levels of BMS and control groups, but subjects in BMS group had slightly, not significantly, higher mean levels for IL‐6 compared with controls. Subjects in BMS group had significantly higher mean values for TAI compared with controls (P < 0.05). There were no statistically significant differences in relation to salivary levels of Mg, Zn, Cu, IL‐2, IL‐6 and depression/anxiety between BMS and control groups. Conclusions:  The results of our study indicate that Mg levels could have an impact on symptoms of BMS and further studies are necessary to determine the importance of cytokines in the pathogenesis of BMS.
Bibliography:istex:77FE1DD382AD51A3B6D10D2D1271A3BC590A5C4F
ark:/67375/WNG-C14H0V44-W
ArticleID:JOP734
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0904-2512
1600-0714
DOI:10.1111/j.1600-0714.2008.00734.x